Babita Veer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Babita Veer has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ram Singh
Department of Applied Chemistry Delhi Technological University Delhi India
2 shared publications - Ankita Sahu
ICMR-National Institute of Pathology
1 shared publication - Arun Kumar Jain
Institute of Arts and Sciences, Noda Division, Tokyo University of Science
1 shared publication - Dibyabhaba Pradhan
Bioinformatics Facility, CCRF, AIIMS, New Delhi, India
1 shared publication - Khalid Raza
Department of Computer Science, Jamia Millia Islamia, New Delhi, India
1 shared publication - Mohammad Moshahid Alam Rizvi
Jamia Millia Islamia
1 shared publication
Latest Publications
- 15 July 2023
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 31 (2) , 119-133
In silico screening, synthesis, characterization and biological evaluation of novel anticancer agents as potential COX-2 inhibitors
Background Cyclooxygenase enzyme is frequently overexpressed in various types of cancer and found to play a crucial role in poor prognosis in cancer patients. In current research, we have reported the new COX-2 inhibitors for cancer treatment using computer-aided drug design and experimental validation. Methods A total of 12,795 compounds from the different databases were used to screen against the COX-2 enzyme. It perceived three new compounds with better binding affinity to the enzyme. Afterwards, physicochemical properties and in silico bioactivity were assessed for efficacy, safety, and structural features required for binding. The molecules were synthesized and confirmed by spectroscopic techniques. Later on, molecules were evaluated for their anti-cancer activity using MCF-7, MDA-MB-231 and SiHa cancer cell lines. Results Compound ZINC5921547 and ZINC48442590 (4a, and 4b) reduced the MCF-7, MDA-MB-231, and SiHa cells proliferation potently than parent compounds. The PG-E2 estimation shown, both compounds act through the COX-2 PGE2 axis. Compound 4a and 4b block the cell cycle at G1-S phase and induce cancer cell death. Conclusions We concluded that compounds 4a and 4b effectively promotes cancer cell death via COX-2 PGE2 axis, and further in vivo studies can be evaluated for development in both compounds as anticancer agents. The compilation of this information will help us to generate better outcome through robust computational methods. The high-quality experimental results may pave the way for identifying effective drug candidates for cancer treatment. Graphical abstract
- 15 July 2023
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 31 (2) , 119-133
In silico screening, synthesis, characterization and biological evaluation of novel anticancer agents as potential COX-2 inhibitors
Background Cyclooxygenase enzyme is frequently overexpressed in various types of cancer and found to play a crucial role in poor prognosis in cancer patients. In current research, we have reported the new COX-2 inhibitors for cancer treatment using computer-aided drug design and experimental validation. Methods A total of 12,795 compounds from the different databases were used to screen against the COX-2 enzyme. It perceived three new compounds with better binding affinity to the enzyme. Afterwards, physicochemical properties and in silico bioactivity were assessed for efficacy, safety, and structural features required for binding. The molecules were synthesized and confirmed by spectroscopic techniques. Later on, molecules were evaluated for their anti-cancer activity using MCF-7, MDA-MB-231 and SiHa cancer cell lines. Results Compound ZINC5921547 and ZINC48442590 (4a, and 4b) reduced the MCF-7, MDA-MB-231, and SiHa cells proliferation potently than parent compounds. The PG-E2 estimation shown, both compounds act through the COX-2 PGE2 axis. Compound 4a and 4b block the cell cycle at G1-S phase and induce cancer cell death. Conclusions We concluded that compounds 4a and 4b effectively promotes cancer cell death via COX-2 PGE2 axis, and further in vivo studies can be evaluated for development in both compounds as anticancer agents. The compilation of this information will help us to generate better outcome through robust computational methods. The high-quality experimental results may pave the way for identifying effective drug candidates for cancer treatment. Graphical abstract
- 1 December 2021
- Published by Bentham Science Publishers Ltd. in Letters in Organic Chemistry
- Vol. 18 (12) , 987-995
Plant Extract-Assisted Green Synthesis of 2-Arylimidazo [1,2-A] Pyridine and Benzimidazole Derivatives
A green and efficient method for the synthesis of 2-arylimidazo [1, 2-a] pyridine (3) and benzimidazole (8) derivatives has been developed using plant extracts. The different plant part extracts of Terminalia chebula, Punica granatum, and Aegle marmelos have been studied. The aqueous fruit extract of Terminalia chebula gave better results. The synthetic method has been optimized with respect to plant extract quantity, pH of the reaction, and yield. The developed protocol showed several advantages like mild reaction conditions, short reaction time, high yield, and reduced environmental impact.
- 1 December 2021
- Published by Bentham Science Publishers Ltd. in Letters in Organic Chemistry
- Vol. 18 (12) , 987-995
Plant Extract-Assisted Green Synthesis of 2-Arylimidazo [1,2-A] Pyridine and Benzimidazole Derivatives
A green and efficient method for the synthesis of 2-arylimidazo [1, 2-a] pyridine (3) and benzimidazole (8) derivatives has been developed using plant extracts. The different plant part extracts of Terminalia chebula, Punica granatum, and Aegle marmelos have been studied. The aqueous fruit extract of Terminalia chebula gave better results. The synthetic method has been optimized with respect to plant extract quantity, pH of the reaction, and yield. The developed protocol showed several advantages like mild reaction conditions, short reaction time, high yield, and reduced environmental impact.